Drug Shortage Report for ZYCLARA

Last updated on 2025-08-06 History
Report ID 237210
Drug Identification Number 02340445
Brand name ZYCLARA
Common or Proper name ZYCLARA
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) IMIQUIMOD
Strength(s) 3.75%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 7.5g
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-11-01
Actual start date 2024-11-05
Estimated end date 2025-08-08
Actual end date 2025-08-05
Shortage status Resolved
Updated date 2025-08-06
Company comments delay in production
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2025-08-06 French Compare
v27 2025-08-06 English Compare
v26 2025-07-24 French Compare
v25 2025-07-24 English Compare
v24 2025-06-27 French Compare
v23 2025-06-27 English Compare
v22 2025-05-29 French Compare
v21 2025-05-29 English Compare
v20 2025-05-14 French Compare
v19 2025-05-14 English Compare
v18 2025-05-14 English Compare
v17 2025-05-01 French Compare
v16 2025-05-01 English Compare
v15 2025-04-09 French Compare
v14 2025-04-09 English Compare
v13 2025-03-20 French Compare
v12 2025-03-20 English Compare
v11 2025-02-06 French Compare
v10 2025-02-06 English Compare
v9 2024-11-07 French Compare

Showing 1 to 20 of 28